Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Selective inhibitors of VEGF and FGF tyrosine kinase reported by Zeneca

April 21, 1999

AACR news: squalamine evaluated for activity in prostate and lung cancer models

April 20, 1999

Potent and long-lasting GnRH antagonist presented by Ferring

April 20, 1999

FDA grants priority review status to Alza' sNDA for Doxil in ovarian cancer

April 20, 1999

SBR-170: a new bioreductive alkylating agent selected for further evaluation

April 20, 1999

BNP-7787 protects against taxane- and platinum-associated neurotoxicity

April 20, 1999

Further phase I data presented for bizelesin at AACR meeting

April 20, 1999

Structural Bioinformatics awarded SBIR grant for HER2 antagonists

April 20, 1999

News from AACR: 9-NC does not require conversion to 9-AC to exert antitumor activity

April 19, 1999

NX-211 compared to free lurtotecan regarding pharmacokinetics, toxicity and efficacy

April 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...